Author: healthadmin

Materials scientists have designed a brain-stimulating contact lens that is as effective as Prozac in treating depression in mice. The soft, clear contact lenses contain electrodes that send gentle electrical signals through the retina to the brain, stimulating specific brain areas associated with depression. Published in Cell Press Journal on May 14, 2026 cell report physical scienceThe paper shows that after three weeks of treatment with contact lenses, depressed mice showed behavioral, neurological, and physiological signs of depression. Our research opens up a completely new frontier in treating brain diseases through the eyes. We believe this wearable, drug-free approach…

Read More

A child’s future heart health may be partially shaped before birth, reports a new Northwestern Medicine study that finds pregnancy complications are associated with poorer cardiovascular health in offspring more than 20 years later. The study found that young adults whose mothers had high blood pressure during pregnancy (either pregnancy-related hypertension, preeclampsia, or eclampsia) had more signs of early artery damage, high blood pressure, high body mass index, and high blood sugar than their peers. The authors said their study adds to growing evidence that cardiovascular risk can be transmitted across generations through a combination of biological, environmental, and behavioral…

Read More

With the FDA now rudderless with the announcement that Commissioner Marty McCully, M.D., is resigning, voices across the biopharmaceutical industry are speaking out in favor of Richard Pazdol, M.D., the FDA’s former top drug regulator, as President Donald Trump’s obvious choice to be the agency’s next commissioner. But it remains unclear whether Pazdur wants the job, despite a vote of confidence in a letter to Trump signed by more than 100 industry leaders, including pharmaceutical and biotech CEOs, partners at venture capital firms and directors of patient advocacy groups. Last month, he told Fierce that another administration would need to…

Read More

Every year, thousands of Americans develop chronic, persistent symptoms such as fatigue, cognitive impairment (“brain fog”), and other debilitating problems following acute infections with Lyme disease, COVID-19, and other pathogens. Efforts to identify the cause and develop treatments have been unsuccessful. But 16 leading researchers think they know part of the problem: research design. In the article brainResearchers from institutions such as , Rutgers University, National Institutes of Health, Rockefeller University, New York Medical College, Mount Sinai Icahn School of Medicine, Stony Brook University, and Cold Spring Harbor Laboratory argue that studies of chronic diseases related to infectious diseases are…

Read More

Scientists have discovered an amazing variety of marine life hidden deep under the sea off the coast of Ningaloo, Western Australia. This includes evidence of giant squid and several other species that may be unknown to science. The discovery comes from research led by Curtin University that investigated the Cape Ranges and Croats submarine canyon, about 1,200 kilometers north of Perth. The expedition was led by the Western Australian Museum aboard the Schmidt Oceanographic Institute’s research vessel R/V. falconsresearchers collected more than 1,000 samples from depths reaching 4,510 meters. Rather than relying solely on cameras or captive animals, the researchers…

Read More

Early and accurate prognostic assessment is important to prevent disease progression in liver failure. Thyroid hormones (TH), especially triiodothyronine (T3), are important metabolic regulators and play an important role in liver regeneration. Liver failure is often associated with non-thyroid disease syndrome (NTIS), which is characterized by normal or slightly elevated TSH and T4 but low T3. This review examines the pathophysiological regulation of the hypothalamic-pituitary-thyroid (HPT) axis in liver failure, focuses on the prognostic value of the TH profile (TSH, T3, T4), and discusses the controversy surrounding TH replacement therapy (THRT) in acute chronic liver failure (ACLF) with NTIS. introduction…

Read More

Using artificial intelligence for creative tasks tends to make human outcomes more uniform at the population level. Recent preprint research provides evidence that while these tools may improve individual performance, they contribute to an overall reduction in the diversity of ideas among different users. This widespread reliance on automated assistance can reduce the scope of concepts in collaborative environments. Generative artificial intelligence refers to computer programs that can create new text, images, or other media based on a user’s instructions. The most common of these tools rely on large language models. Developers build these models by feeding them billions of…

Read More

New Meta-Analysis in May 2026 Issue JNCCN – National Comprehensive Cancer Network Journal provide the latest evidence that methylphenidate-type psychostimulants, a class of drugs that increase the availability of dopamine and norepinephrine in the brain, can provide meaningful relief from cancer-related fatigue. According to some estimates, cancer-related fatigue affects nearly three-quarters of people living with cancer, yet remains one of the most undertreated conditions in oncology. According to the findings of this study, use of the prescription drugs methylphenidate (MPH) or dexmethylphenidate (d-MPH) was associated with significant improvements in fatigue scores compared to placebo across widely validated scales. These effects…

Read More

Even in the primary visual cortex, a brain region named for its specialized role in processing the basic features of what we see, not all neurons ultimately respond to the call to process properties of visual input. Perhaps that’s because each neuron receives a wide variety of inputs through thousands of circuit connections, or “synapses,” and must choose whether to respond to visual or other information. In a new study in mice, neuroscientists at the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology have uncovered how visual processing neurons bring order to this input and accomplish…

Read More

The FDA aims to save money on approved drugs. Through the newly proposed reuse initiative, the agency hopes to help address unmet medical needs by discovering new uses for previously approved medicines. New uses for previously approved drugs, whether for new indications or new eligible patient populations, will leverage existing safety data to accelerate treatment availability, the FDA explained in a May 11 release. “Despite promising science, too many patients lack effective treatment options,” explained outgoing FDA Commissioner Marty McCulley, M.D., in a statement. “Drug repurposing allows us to better leverage available scientific data to provide effective treatment options to…

Read More